German parliament approves cost-cutting health bill, pharma industry warns of exit risk

German federal parliament voted to pass a bill aimed at reducing domestic healthcare expenditures.

The legislation seeks to curb spending on medicines and other health services as part of a broader effort to control the nation's budget.

The country's main pharmaceutical trade association criticized the measure, saying it could force drugmakers to leave the market.

The debate highlighted tension between cost-containment goals and industry concerns about profitability and patient access.